Search Results - Wardley, Andrew
- Showing 1 - 2 results of 2
-
1
Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge by Jackisch, Christian (Author) , Cortazar, Patricia (Author) , Geyer, Charles E. (Author) , Gianni, Luca (Author) , Gligorov, Joseph (Author) , Machackova, Zuzana (Author) , Perez, Edith A. (Author) , Schneeweiss, Andreas (Author) , Tolaney, Sara M. (Author) , Untch, Michael (Author) , Wardley, Andrew (Author) , Piccart, Martine (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic brea... by Miles, David W. (Author) , Chan, Arlene (Author) , Dirix, Luc Y. (Author) , Cortés, Javier (Author) , Pivot, Xavier (Author) , Tomczak, Piotr (Author) , Delozier, Thierry (Author) , Sohn, Joo Hyuk (Author) , Provencher, Louise (Author) , Puglisi, Fabio (Author) , Harbeck, Nadia (Author) , Steger, Guenther G. (Author) , Schneeweiss, Andreas (Author) , Wardley, Andrew M. (Author) , Chlistalla, Andreas (Author) , Romieu, Gilles (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Breast Neoplasms
Docetaxel
Drug Administration Schedule
ErbB Receptors
Female
HER2-postive early breast cancer
Humans
Middle Aged
Neoadjuvant therapy
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neratinib
Pertuzumab
Placebos
T-DM1
Taxoids
Trastuzumab